Gabelli Funds »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by Gabelli Funds

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by Gabelli Funds from 13F filings

Historical chart of Gabelli Funds investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by Gabelli Funds consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by Gabelli Funds

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.3M 2.1M 1.09

More positions owned by Gabelli Funds

Newmont Corp Equity (NEM)
Nvidia Corp Equity (NVDA)
National Fuel Gas Equity (NFG)
Ametek Equity (AME)
Microsoft Corp Equity (MSFT)
Nextera Energy Equity (NEE)
Mastercard Inc - A Equity (MA)
Bank Of New York Mellon Corp Equity (BNY)
Gatx Corp Equity (GATX)
Deere & Co Equity (DE)
Mueller Industries Equity (MLI)
American Express Equity (AXP)
Amazon.com Equity (AMZN)
Madison Square Garden Sports Equity (MSGS)
Crane Equity (CR)

View all positions for Gabelli Funds

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Linden Advisors
Camden Asset Management
LMR Partners
Readystate Asset Management
Calamos Advisors
Jump Financial
Context Capital Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Oaktree Capital Management
Polar Securities
Lazard Asset Management
Shenkman Capital Management
Point72 Asset Management

View all funds holding Arrowhead Pharmaceuticals In Note 1/1